Combs Andrew
Prelude Therapeutics Incorporated · Chief Chemistry Officer
Combs Andrew is listed in public filings as officer: Chief Chemistry Officer. This Combs Andrew insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Prelude Therapeutics Incorporated (PRLD). Investors use Combs Andrew's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $529k230k shares | Grant / ExerciseFeb 4, 2026 | $529.0K230k shares | $2.30 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $332k480.1k shares | BuyMar 25, 2025 | $69.3K100k shares | $0.6925 | -- | |
| $194k175k shares | Grant / ExerciseFeb 4, 2025 | $194.3K175k shares | $1.11 | -- | |
| $516k377.6k shares | BuyDec 23, 2024 | $82.0K60k shares | $1.37 | -- | |
| $365k317.6k shares | BuyDec 20, 2024 | $3.5K3.1k shares | $1.15 | -- |